What are the adverse effects of levofloxacin?

Adverse Effects of Levofloxacin

Levofloxacin is generally well-tolerated with a favorable safety profile compared to other fluoroquinolones, but clinicians must remain vigilant for several potentially serious adverse effects, particularly gastrointestinal disturbances, neurologic effects, cutaneous reactions, and rare but severe complications including tendon rupture, QT prolongation, and hepatotoxicity.

Common Adverse Effects (Occur in 0.5-1.8% of patients)

Gastrointestinal Effects

• Nausea and bloating occur in 0.5-1.8% of patients 1, 2
• Diarrhea is among the most common adverse reactions (≥3%) 2
• Vomiting occurs in approximately 0.4-0.6% of patients 2
• These gastrointestinal effects are the most frequent reason for drug discontinuation (1.2-1.4% of patients) 2

Neurologic Effects

• Dizziness, insomnia, tremulousness, and headache occur in approximately 0.5% of patients 1, 2
• Headache is among the most common adverse reactions (≥3%) 2
• Insomnia occurs in ≥3% of patients 2

Cutaneous Reactions

• Rash, pruritus, and photosensitivity occur in 0.2-0.4% of patients 1, 2
• Levofloxacin has one of the lowest phototoxic potentials among fluoroquinolones 3, 4
• Most cutaneous manifestations are mild (89%), including maculopapular rash (37%), pruritus (20%), urticaria (14%), and erythema (11%) 5
• Onset is typically rapid (89% within 24 hours) and reactions resolve fully after drug discontinuation 5

Serious Adverse Effects (Rare but Clinically Significant)

Tendon Disorders

• Risk is higher in patients over 60 years, those taking corticosteroids, and transplant recipients 2
• Tendonitis occurs in less than 0.1% of patients 3
• Patients should discontinue levofloxacin immediately if they experience tendon pain, swelling, or weakness 2

Central Nervous System Toxicity

• Convulsions occur in less than 0.1% of patients 3
• Psychotic episodes occur in less than 0.1% of patients 3
• Levofloxacin has one of the lowest potentials for CNS adverse events among fluoroquinolones 6, 4
• Rare cases of encephalopathy with severe hyperventilation and psychosis have been reported 7

Cardiovascular Effects

• QT interval prolongation can occur, though the rate is extremely low (1 in 15 million prescriptions) 4
• Patients with personal or family history of QT prolongation, hypokalemia, bradycardia, or recent myocardial ischemia are at higher risk 2
• Significantly lower cardiovascular risk compared to sparfloxacin and moxifloxacin 4

Hepatotoxicity

• Severe hepatotoxicity including acute hepatitis and fatal events have been reported 2
• The notification rate of severe liver injuries is less than 1 per 5 million prescriptions 3
• Significantly lower hepatotoxicity risk compared to trovafloxacin (which caused 140 cases of hepatic problems) 4
• Patients should discontinue immediately if they develop signs of liver injury: loss of appetite, nausea, vomiting, fever, weakness, right upper quadrant tenderness, jaundice, or dark urine 2

Peripheral Neuropathy

• May be irreversible 2
• Symptoms include pain, burning, tingling, numbness, and weakness 2
• Patients should immediately discontinue treatment if peripheral neuropathy symptoms develop 2

Hypersensitivity Reactions

• Can occur even after the first dose 2
• Patients should discontinue at the first sign of skin rash, hives, rapid heartbeat, difficulty swallowing or breathing, or angioedema 2

Blood Glucose Disturbances

• Both hypoglycemia and hyperglycemia can occur 2, 6
• Levofloxacin has low rates of dysglycemia compared to gatifloxacin (which was withdrawn from the market for this reason) 6

Musculoskeletal Effects in Children

• Concerns about effects on bone and cartilage growth exist, though long-term use has not been approved in children 1
• However, experts agree the drug should be considered for children with multidrug-resistant tuberculosis 1
• Studies show arthralgia may occur in up to 25% of patients in some populations 8

Special Populations and Precautions

Pregnancy

• Fluoroquinolones should be avoided in pregnancy due to teratogenic effects 1

Renal Impairment

• Levofloxacin is cleared primarily (80%) by the kidney 1
• Dosage adjustment (750-1,000 mg three times weekly) is required if creatinine clearance is less than 50 mL/minute 1
• Not cleared by hemodialysis; supplemental doses after dialysis are not necessary 1

Hepatic Disease

• Drug levels are not affected by hepatic disease 1
• Presumed safe in severe liver disease but should be used with caution 1

Drug Interactions and Administration Considerations

• Antacids containing magnesium or aluminum, sucralfate, metal cations (iron), and multivitamins with zinc must be taken at least 2 hours before or after levofloxacin 1, 2
• Adequate hydration should be maintained to prevent crystalluria 2

Overall Safety Profile

Levofloxacin has one of the best safety profiles among fluoroquinolones 6, 4:

• Overall adverse drug reaction rate of only 2% (compared to 2-10% for other fluoroquinolones) 4
• Discontinuation rate due to adverse reactions: 4.3% overall 2
• Most adverse reactions are mild and reversible with drug discontinuation 5